what does the future hold for biosimilars in the united states?
Published 9 years ago • 30 plays • Length 0:48Download video MP4
Download video MP3
Similar videos
-
1:27
what is the future of biosimilars?
-
5:44
role of biosimilars in the specialty marketplace
-
1:33
the long-term impact of biosimilars
-
1:00
the long-term impact of biosimilars on specialty pharmacy
-
11:15
pricing of biosimilars with biologics and other biosimilars
-
49:42
cultivating a vibrant u.s. market for biosimilars: a conversation with fda’s scott gottlieb - part 1
-
3:00
biosimilars: complex copycat drugs
-
3:33
biosimilars: manufacturing and inherent variation
-
3:07
the promise of biosimilars
-
3:02
biosimilar medications — what patients need to know
-
2:13
what is bioinformatics
-
2:03
future of health focus on biosimilars
-
4:12
the basics of biosimilars
-
0:58
biosimilars in specialty pharmacy
-
1:14
what has been the manufacturer response to biosimilars?
-
16:32
annexin pharmaceuticals | investing in life science 2024
-
1:05:56
what’s next? biosimilars: the future of biosimilar drugs in the u.s.
-
1:27
how do biosimilars differ from generics?
-
1:00
biosimilars continue trending upward
-
1:29
biosimilars poised to impact specialty pharmacy
-
14:19
regulatory pathway for biosimilars
-
4:55
factors determining inclusion of biosimilars on the formulary